VZV Infected Cell Extract - New Lot2
|Host Cell||Normal Human Dermal Fibroblast (NHDF)|
|Cell Line Characterization||Confirmed Negative for HIV and Hepatitis B|
|Purity||Infected cell extract enriched for viral proteins|
|Inactivation||Verified by tissue culture infectivity assay.|
|Supplied In||100 mM Glycine pH 9.5|
|Protein Concentration||0.50 mg/ml|
|Fill Volume||1.03 ml (VV037-1) or 25.2 ml (VV037-25)|
|ELISA (IgG) Titer||>1:3,200|
|Western Blot Titer||50 µg/cm|
|Reference and/or Additional Reading||J. Med. Virology (1984), 13(4):361|
Antigen is Virusys # VV037 VZV Infected Cell Extract coated at various dilutions in PBS. Primary antibodies are human plasmas previously characterized for VZV serology. See SOP-138 for procedure.
Western Blot Results
Antigen is Virusys # VV037 VZV Infected Cell Extract at 50 µg/cm. Primary antibodies are human plasmas previously characterized for VZV serology. See SOP-128 for procedure.
This product is intended for research and manufacturing uses only. It is not a diagnostic device. It is supplied frozen on dry ice - upon receipt, store at -70°C. Product degradation will result from multiple freeze/thaw cycles. It is suggested that the antigen be stored in use size aliquots and thawed just prior to use. Storage at 2 - 8°C for up to twelve hours is acceptable for unused portions.